INKON Life Technology Co., Ltd. (SHE:300143)
China
· Delayed Price · Currency is CNY 11.26
-0.03 (-0.27%)
At close: Apr 29, 2026
INKON Life Technology Revenue
INKON Life Technology had revenue of 496.39M CNY in the quarter ending March 31, 2026, with 21.36% growth. This brings the company's revenue in the last twelve months to 1.97B, up 27.12% year-over-year. In the year 2025, INKON Life Technology had annual revenue of 1.89B with 20.93% growth.
Revenue (ttm)
1.97B
Revenue Growth
+27.12%
P/S Ratio
4.25
Revenue / Employee
741.14K
Employees
2,662
Market Cap
8.39B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.89B | 326.33M | 20.93% |
| Dec 31, 2024 | 1.56B | 88.44M | 6.01% |
| Dec 31, 2023 | 1.47B | 314.55M | 27.20% |
| Jan 1, 2023 | 1.16B | 66.38M | 6.09% |
| Jan 1, 2022 | 1.09B | 60.99M | 5.93% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shinva Medical Instrument | 9.58B |
| HOB Biotech Group Corp.,Ltd | 399.65M |
| Sino Medical Sciences Technology | 525.41M |
| Edan Instruments | 2.09B |
| Guangzhou Wondfo Biotech Co.,Ltd | 1.87B |
| Shenzhen YHLO Biotech | 1.81B |
| Xiangyu Medical Co.,Ltd | 774.78M |
| Sinocare | 4.86B |